Never reuse needles or syringes, as this introduces contamination risk and dulled needles cause more tissue damage and injection site irritation
Unlike cagrilintide, tirzepatide has completed a large Phase 3 program and reached the market
In the United States, over 46% of Americans medically qualify to receive life-changing weight loss medications
In December 2014, the Food and Drug Administration (FDA) approved liraglutide for weight loss, and semaglutide was approved for diabetes in 2017 and obesity in 2021, opening a new era of obesity treatment
This litigation process is critical in managing large-scale, complex litigation efficiently, preventing the duplication of discovery, avoiding conflicting rulings and schedules, and conserving the resources of the parties, their counsel, and the judiciary